Inventor
Gary R. Ostroff
Inventor
Worcester, MA, US
Overview
Patents· 38 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C08BPolysaccharides15%
A01NPreservation of bodies of humans or animals or plants or parts thereof7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%
C12NMicroorganisms or enzymes5%
Y02ATechnologies for adaptation to climate change5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
B82YSpecific uses or applications of nanostructures2%
C08LCompositions of macromolecular compounds2%
PatentTitleYear
10,729,130Nematicidal compositions and methods of using them202010,667,512Terpene-containing compositions and methods of making and using them202010,638,750Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them202010,258,033Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral and L-carvone201910,004,229Nematicidal compositions and methods of using them20189,682,135'Drug delivery product and methods'20179,662,299'Yeast cell wall particles for receptor-targeted nanoparticle delivery'20179,655,360'Nematicidal compositions and methods of using them'20179,439,416'Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone'20169,242,857'Yeast cell wall particles for receptor-targeted nanoparticle delivery'20168,865,679'Use of beta-glucans against biological warfare weapons and pathogens including anthrax'20148,637,045'Therapy for lysosomal enzyme deficiencies'20148,580,275'Drug delivery product and methods'20138,563,531'Methods of using beta glucan as a radioprotective agent'20138,389,485'Encapsulated nanoparticles for nucleic acid delivery'20138,007,814'Therapy for lysosomal enzyme deficiencies'20117,786,094'Use of beta-glucans against biological warfare weapons and pathogens including anthrax'20107,740,861'Drug delivery product and methods'20107,566,704'Very high molecular weight β-glucans'20097,022,685'Very high molecular weight β-glucans'20066,369,216'Very high molecular weight -glucans'20026,022,703'Expression of DNA sequences derived from nocardioform microorganisms'20005,849,720'Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans'19985,817,643'Underivatized, aqueous soluable .beta.(1-3) glucan, composition and method of making same'19985,811,542'Method for producing soluble glucans'19985,783,569'Uses for underivatized, aqueous soluble .beta.(1-3) glucan and compositions comprising same'19985,741,495'Glucan drug delivery system and adjuvant'19985,663,324'Method for producing underivatized, aqueous soluble .beta.(1-3) glucan'19975,633,369'Method for producing soluble glucans'19975,622,939'Glucan preparation'19975,622,940'Inhibition of infection-stimulated oral tissue destruction by .beta.(1,3)-glucan'19975,607,677'Glucan drug delivery system and adjuvant'19975,532,223'Use of aqueous soluble glucan preparations to stimulate platelet production'19965,504,079'Method for immune system activation by administration of a .beta.(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4'19965,488,040'Use of neutral soluble glucan preparations to stimulate platelet production'19965,322,841'Method for producing neutral glucans for pharmaceutical applications'19945,032,401'Glucan drug delivery system and adjuvant'19914,595,660'Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis, mutants and substantially stably transformed mutants of Bacillus subtilis, and methods for utilizing the transformed mutants'1986Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1986–2000Based in Needham, MA, US· patent location history
1991–1998Patents assigned to ALPHA BETA TECHNOLOGY (15)· patent assignee history
1991–2020Based in Worcester, MA, US· patent location history
2010–2017Patents assigned to UNIV MASSACHUSETTS (8)· patent assignee history
2013–2016Patents assigned to OSTROFF GARY R (6)· patent assignee history
2016–2020Patents assigned to EDEN RESEARCH PLC (7)· patent assignee history
2016–2020Patents assigned to CLOUD ELIZABETH (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALPHA BETA TECHNOLOGY | 15 | 1991–1998 |
| UNIV MASSACHUSETTS | 8 | 2010–2017 |
| EDEN RESEARCH PLC | 7 | 2016–2020 |
| OSTROFF GARY Rself | 6 | 2013–2016 |
| CLOUD ELIZABETH | 4 | 2016–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Worcester, Massachusetts, US | 36 | 1991–2020 |
| Needham, Massachusetts, US | 2 | 1986–2000 |